Recognition of oligiosaccaride molecular targets by polycationic small molecule inhibitors and treatment of immunological disorders and infectious diseases
View Patent ↗Small molecule polycationic agents are used to modulate or interrupt biological processes by binding to oligosaccharide-based biomolecules. Compounds that inhibit nitric oxide, TNFα or other immunomodulators are provided and are useful for treating immunological disease and disease of an infectious disorder.
1. A compound selected from the group consisting of
and salts thereof.
2. The compound of claim 1 being represented by the formula:
3. The compound of claim 1 being represented by the formula:
4. The compound of claim 1 being represented by the formula:
5. The compound of claim 1 being represented by the formula:
6. A composition comprising a compound according to claim 1 .
7. A composition comprising a compound according to claim 2 .
8. A composition comprising a compound according to claim 3 .
9. A composition comprising a compound according to claim 4 .
10. A composition comprising a compound according to claim 5 .